Raymond James & Associates’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $9.28M | Buy |
81,235
+11,798
| +17% | +$1.35M | 0.01% | 1272 |
|
|
2024
Q2 | $5.24M | Buy |
69,437
+3,105
| +5% | +$234K | ﹤0.01% | 1535 |
|
|
2024
Q1 | $4.53M | Buy |
66,332
+14,779
| +29% | +$1.01M | ﹤0.01% | 1655 |
|
|
2023
Q4 | $3.24M | Sell |
51,553
-2,363
| -4% | -$148K | ﹤0.01% | 1804 |
|
|
2023
Q3 | $2.75M | Sell |
53,916
-693
| -1% | -$35.3K | ﹤0.01% | 1822 |
|
|
2023
Q2 | $2.73M | Buy |
54,609
+47,009
| +619% | +$2.35M | ﹤0.01% | 1864 |
|
|
2023
Q1 | $285K | Buy |
+7,600
| New | +$285K | ﹤0.01% | 3238 |
|